LON:OBD Oxford BioDynamics (OBD) Share Price, News & Analysis → Stock-Picking AI Predicts #1 Stock of 2024 (From Altimetry) (Ad) Free OBD Stock Alerts GBX 8 -0.10 (-1.23%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range 8▼ 8.4850-Day Range 8▼ 13.5552-Week Range 7.80▼ 52Volume526,034 shsAverage Volume781,698 shsMarket Capitalization£24.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsInsider Trades Get Oxford BioDynamics alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Oxford BioDynamics Stock (LON:OBD)Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.Read More OBD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OBD Stock News HeadlinesMay 3, 2024 | americanbankingnews.comOxford BioDynamics (LON:OBD) Stock Crosses Below Fifty Day Moving Average of $9.89March 14, 2024 | msn.comWhere To Dine In Oxford For A Special OccasionMay 5, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.March 13, 2024 | uk.investing.comOxford Biodynamics PLC (OBD)December 10, 2023 | msn.comOxford researchers develop early detection test for Parkinson'sNovember 3, 2023 | morningstar.comOxford BioDynamics PLC OBDOctober 18, 2023 | finance.yahoo.comBupa UK to cover EpiSwitch® CiRT for customers with cancerSeptember 26, 2023 | msn.comMARKET REPORT: Shares in prostate test firm more than doubleMay 5, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.September 4, 2023 | finance.yahoo.comSeveral Insiders Invested In Oxford BioDynamics Flagging Positive NewsAugust 1, 2023 | lse.co.ukOxford BioDynamics proposes GBP7 million fundraise for EpiSwitch plansJuly 18, 2023 | uk.finance.yahoo.comOBD.L - Oxford BioDynamics PlcMay 30, 2023 | marketwatch.comOxford BioDynamics Shares Fall on Wider 1H Loss, Need for More CashMay 2, 2023 | marketwatch.comOxford BioDynamics Receives $963,000 Award for Adverse Response Oncology TestFebruary 10, 2023 | msn.comThis blood test can detect prostate cancer with 94 percent accuracyFebruary 8, 2023 | msn.comScientists create ‘impressive’ new blood test for prostate cancer that is 94% accurateFebruary 7, 2023 | msn.comNew blood test for prostate cancer is 94% accurate, researchers sayFebruary 2, 2023 | finance.yahoo.comThe Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More SharesJanuary 29, 2023 | finance.yahoo.comOxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)December 19, 2022 | finance.yahoo.comOxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare ConferenceDecember 16, 2022 | finance.yahoo.comMassachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic Stratification of Fast Progression ALSOctober 8, 2022 | fool.co.ukOxford BioDynamicsOctober 8, 2022 | finance.yahoo.comOxford BioDynamics (LON:OBD) Will Have To Spend Its Cash WiselyOctober 7, 2022 | marketwatch.comOxford BioDynamics to Raise Up to GBP12 Mln to Boost Cancer Test CommercializationJune 28, 2022 | lse.co.ukOxford BioDynamics shares drop as it might need funding by early 2023June 21, 2022 | barrons.comOxford BioDynamics's Checkpoint Inhibitor Response Test (EpiSwitch(R) CiRT) Now Available in the UKMarch 11, 2022 | finance.yahoo.comOxford BioDynamics Plc (OBD.L)See More Headlines Receive OBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/16/2020Today5/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBD CUSIPN/A CIKN/A Webwww.oxfordbiodynamics.com Phone+44-1865-518910FaxN/AEmployees45Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-10,830,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-250.52% Return on Assets-46.27% Debt Debt-to-Equity Ratio106.34 Current Ratio1.79 Quick Ratio2.80 Sales & Book Value Annual Sales£176,000.00 Price / Sales141.75 Cash FlowGBX 2.01 per share Price / Cash Flow3.98 Book ValueGBX 3 per share Price / Book2.67Miscellaneous Outstanding Shares311,860,000Free FloatN/AMarket Cap£24.95 million OptionableNot Optionable Beta0.44 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Jon Anthony Joseph Burrows B.Sc. (Age 62)M.Sc., Ph.D., CEO & Executive Director Comp: $606kMr. Paul Leslie Stockdale F.C.A. (Age 49)M.A., CFO & Executive Director Comp: $239kDr. Alexandre Akoulitchev M.A. (Age 62)Ma (Oxon), Ph.D., Chief Scientific Officer & Executive Director Comp: $276kMr. Thomas G. Guiel B.A.Chief Operating OfficerDavid BlumSenior Vice President of MarketingDr. Steven ArrivoSenior Vice President of Business & Corporate DevelopmentDr. Ewan Hunter B.Sc.Ph.D., Ph.D., (KCL), Chief Data OfficerT. DemainCompany SecretaryMore ExecutivesKey CompetitorsSareumLON:SAROncimmuneLON:ONCDestiny PharmaLON:DESTOptiBiotix HealthLON:OPTISkinBioTherapeuticsLON:SBTXView All CompetitorsInsidersStephen Charles DiggleSold 125,000 sharesTotal: £4.25 M ($34.00/share)Stephen Charles DiggleSold 777,000 sharesTotal: £29.53 M ($38.00/share)Stephen Charles DiggleSold 115,000 sharesTotal: £5.18 M ($45.00/share)View All Insider Transactions OBD Stock Analysis - Frequently Asked Questions How have OBD shares performed in 2024? Oxford BioDynamics' stock was trading at GBX 28 at the start of the year. Since then, OBD stock has decreased by 71.4% and is now trading at GBX 8. View the best growth stocks for 2024 here. How were Oxford BioDynamics' earnings last quarter? Oxford BioDynamics Plc (LON:OBD) released its earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) EPS for the quarter. What other stocks do shareholders of Oxford BioDynamics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL). How do I buy shares of Oxford BioDynamics? Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:OBD) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe only accurate crypto trading system I know …Weiss RatingsDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
